HAVCR2 and acute myeloid leukemia: Darwish et al. showed that blocking TIM-3 in AML cell lines inhibited cell proliferation [133], whereas Kikushige et al. observed in mice models that anti-TIM3 antibody did not harm reconstitution of normal human HSCs but blocked engraftment of AML after xenotransplantation [134].